[1]
“Reassessing Chelerythrine as a Candidate Therapy for Nasopharyngeal Carcinoma”, J Environ Biol Sci, vol. 2, no. 1, pp. 1–3, Nov. 2026, doi: 10.64142/jebs.2.1.18.